Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 399

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation*

Hale, Michael D., Nicholls, Andrew J., Bullingham, Roy E.S., Hené, Ronald, Hoitsma, A., Squifflet, Jean-Paul, Weimar, W., Vanrenterghem, Yves, Van de Woude, Fokko J., Verpooten, Gert A.·1998·Clinical Pharmacology & Therapeutics

Abstract

BACKGROUND: Mycophenolate mofetil, a pro-drug for mycophenolic acid, reduces the likelihood of allograft rejection after renal transplantation. We studied the relationship between mycophenolic acid pharmacokinetics and the likelihood of rejection in a randomized concentration-controlled trial. METHODS: Under double-blind conditions, recipients of kidney transplants were followed for evidence of allograft rejection for 6 months. In addition to mycophenolate mofetil, patients received usual doses of cyclosporine (INN, ciclosporin) and corticosteroids. The dose of mycophenolate mofetil (given twice daily) was controlled by feedback, with mycophenolic acid area under the concentration-time curve (AUC) as the controlled variable. Patients were randomly assigned to 1 of 3 target AUC groups. RESULTS: Logistic regression analysis showed a significant (P < .0001) relationship between mycophenolic acid AUC and the likelihood of rejection. High mycophenolic acid values were associated with a very low probability of rejection. An AUC of 15 micrograms.h/mL yielded 50% of maximal achievable efficacy with a 4% change of efficacy for a 1 microgram.h/mL change in AUC at the midpoint of the logistic curve. Exploratory analyses showed other variables (e.g., the maximum observed plasma concentration, predose plasma concentration, and drug dose) had poorer predictive power for the rejection outcome. Bivariate regression confirmed the importance of AUC as a highly predictive variable and showed low predictive value of other variables, once the contribution of AUC had been considered. The characteristic side effects of mycophenolate mofetil therapy appeared related to drug dose but not to mycophenolic acid concentration. CONCLUSIONS: The AUC of mycophenolic acid is predictive of the likelihood of allograft rejection after renal transplantation in patients receiving mycophenolate mofetil.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0009-9236(98)90058-3

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 399

Metadata

Authors
Hale, M. D., Nicholls, A. J., Bullingham, R. E. S., Hené, R., Hoitsma, A., Squifflet, J.-P., Weimar, W., Vanrenterghem, Y., Van de Woude, F. J., & Verpooten, G. A.
Venue
Clinical Pharmacology & Therapeutics
Publisher
Wiley
Published
1998-12
Volume
64
Issue
6
Pages
672-683
ISSN
  • 0009-9236 (ISSN-L)
  • 1532-6535
OpenAlex
W1981535286
Cited by
399
References
6
FWCI
11.99
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation*. https://app.cochat.ai/papers/10.1016/s0009-9236(98)90058-3
The paper
Hale, M. D., Nicholls, A. J., Bullingham, R. E. S., Hené, R., Hoitsma, A., Squifflet, J.-P., Weimar, W., Vanrenterghem, Y., Van de Woude, F. J., & Verpooten, G. A. (1998). The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation*. Clinical Pharmacology & Therapeutics. https://doi.org/10.1016/s0009-9236(98)90058-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.